L’amphotéricine B liposomale en prophylaxie secondaire chez les patients VIH+ atteints de leishmaniose viscérale : à propos de cinq cas
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Pathologie Biologie
- Vol. 52 (2) , 66-75
- https://doi.org/10.1016/j.patbio.2003.09.012
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Partial approaches to truth through legitimization and sightSemiotica, 2002
- CASE REPORT: Long-term Remission of Human Immunodeficiency Virus- associated Visceral Leishmaniasis after Initiation of Potent Combination Antiretroviral Treatment: Report of Two CasesJournal of Infection, 2000
- HIV viral load and response to antileishmanial chemotherapy in co-infected patientsAIDS, 1999
- Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.The American Journal of Tropical Medicine and Hygiene, 1998
- Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 casesInfection, 1998
- Visceral leishmaniasis in patients infected with the human immunodeficiency virusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Leishmania and human immunodeficiency virus coinfection: the first 10 yearsClinical Microbiology Reviews, 1997
- Visceral leishmaniasisAIDS, 1991
- Visceral leishmaniasis in patients infected with human immunodeficiency virusJournal of Infection, 1990